Kabra Drugs Ltd

Kabra Drugs Annual Report

Aanjaay Industries Ltd has submitted its Annual Report for FY 2025-2026 and issued notice for its 37th AGM scheduled for 30th September 2026.

Kabra Drugs Annual General Meeting

Aanjaay Industries Limited announced book closure dates from September 24th to September 30th, 2026, for its Annual General Meeting scheduled for September 30th, 2026.

Kabra Drugs Board Meeting Outcome

Aanjaay Industries Limited announced the notice for its 37th Annual General Meeting and approved board agenda items, including the appointment of directors and auditors.

Kabra Drugs Other Announcement

Aanjaay Industries Limited has shifted its registered office from Indore, Madhya Pradesh, to Chennai, Tamil Nadu, effective August 28, 2026.

Kabra Drugs Board Meeting Date

Aanjaay Industries Limited has scheduled a board meeting for September 2, 2026. The agenda includes approving the Director's Report and fixing details for the upcoming AGM.

Kabra Drugs Other Announcement

Aanjaay Industries Limited has filed its updated Board and Committee composition list in compliance with SEBI (LODR) regulations.

Kabra Drugs Management Change

Director Ms. Anand Anitha has resigned from the Board of Aanjaay Industries Limited, effective August 12, 2026, citing personal reasons.

Kabra Drugs Q1 FY27 Results: Turns Profitable, Net Profit ₹2.1 Cr

Kabra Drugs Ltd reported revenue from operations of ₹46.2 Cr (+541.7% YoY) and net profit of ₹2.1 Cr for Q1 FY27.

Key figure

Net profit ₹2.1 Cr

Kabra Drugs Board Meeting Date

Aanjaay Industries Limited will hold a Board Meeting on 12th August 2026. The meeting will consider the unaudited financial results and a Director's resignation.

Kabra Drugs Other Announcement

Kabra Drugs Ltd has filed its quarterly shareholding pattern for the quarter ended June 30, 2026, in compliance with SEBI regulatory requirements.